|
Online Database of Chemicals from Around the World | Search | Submit | Advertise | |
Home >> Chemical Listing >> Neurokinin A>> Market Analysis Reports |
Market Analysis Reports of Neurokinin A |
|
NEUROKININ A (CAS 86933-74-6) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Global Market Report of NEUROKININ A (CAS 86933-74-6) December 2024 Global Market Report of NEUROKININ A (CAS 86933-74-6) December 2024 Neuromedin K (CAS 86933-75-7) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Global Market Report of NEUROKININ A (4-10) (CAS 97559-35-8) December 2024 Global Market Report of (PRO7)-NEUROKININ B (CAS 120814-48-4) December 2024 Global Market Report of neurokinin A (4-10), Nle(10)- (CAS 110863-33-7) December 2024 Global Market Report of NEUROKININ B (CAS 86933-75-7) December 2024 Global Market Report of NEUROKININ B (CAS 86933-75-7) December 2024 Neurokinin (NK) Receptor Antagonist - Pipeline Insight, 2022 ... pipeline development activities for Neurokinin (NK) Receptor Antagonist Pipeline ... activity for Neurokinin (NK) Receptor Antagonist Features the Neurokinin (NK) Receptor ... and opportunities that influence Neurokinin (NK) Receptor Antagonist research & ... Neurokinin 1 (NK1) Receptor Agonist - Pipeline Insight, 2022 ... to the clients within 48 hrs “Neurokinin 1 (NK1) Receptor Agonist - Pipeline ... coverage of pipeline development activities for Neurokinin 1 (NK1) Receptor Agonist Pipeline ... and opportunities that influence Neurokinin 1 (NK1) Receptor Agonist research & ... Neuromedin K Receptor (NK3 Receptor or Neurokinin B Receptor or Tachykinin Receptor 3 or NK3R or TACR3) - Drugs in Development, 2021 ... Neuromedin K Receptor (NK3 Receptor or Neurokinin B Receptor or Tachykinin Receptor 3 o ... K Receptor (NK3 Receptor or Neurokinin B Receptor or Tachykinin Receptor 3 o ... Neuromedin K Receptor (NK3 Receptor or Neurokinin B Receptor or Tachykinin Receptor 3 o ... Antiemetics Drugs Market Size, Trends, Analysis, and Outlook By Drug Type (Serotonin-Receptor Antagonists, Anticholinergics, Dopamine Receptor Antagonists, Neurokinin Receptor Antagonists, Others), By Application (Chemotherapy, Gastroenteritis, Post Operative Surgery, Others), By End-user ( Hospital & Clinics, Retail Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030 ... Antagonists, Anticholinergics, Dopamine Receptor Antagonists, Neurokinin Receptor Antagonists, Others), By Application (Chemotherapy ... Antagonists Anticholinergics Dopamine Receptor Antagonists Neurokinin Receptor Antagonists Others By Application ... Global Antiemetics Market Size Study & Forecast, by Drug Type (Antihistamines, Serotonin Receptor Antagonists, Dopamine Receptor Antagonists, Neurokinin Receptor Antagonists, Anticholinergics, Other Drug Types), by Application (Chemotherapy, Post Operative Surgery, Pregnancy and Gatroenteritis, Other Applications), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), and Regional Analysis, 2023-2030 ... Receptor Antagonists Dopamine Receptor Antagonists Neurokinin Receptor Antagonists Anticholinergics Other Drug ... Ono Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... mineral density. Emend Capsules: Emend is a neurokinin (NK) 1 antagonist. The drug is effective not ... -7847 / MK-0517 (injection): ONO-7847 is a neurokinin (NK) 1 receptor antagonist, the prodrug of ONO ... Neurokinin (NK) Receptor Antagonist -Pipeline Intelligence, 2019 ... within 1-2 Business Days. CmaxInsight’s, “Neurokinin (NK) Receptor Antagonist-Pipeline ... understand the landscape of the Neurokinin (NK) Receptor Antagonist. Pipeline ... and opportunities that influence Neurokinin (NK) Receptor Antagonist R&D Please ... Neurokinin 1 (NK1) Receptor Agonist -Pipeline Intelligence, 2019 ... within 1-2 Business Days. CmaxInsight’s, “Neurokinin 1 (NK1) Receptor Agonist-Pipeline ... to understand the landscape of the Neurokinin 1 (NK1) Receptor Agonist. Pipeline ... and opportunities that influence Neurokinin 1 (NK1) Receptor Agonist R&D Please ... Global Chemotherapy Induced Nausea And Vomiting Therapeutics Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery ... Serotonin Receptor Antagonists Corticosteroids Benzodiazepines Neurokinin NK1 receptor antagonist In Chapter 7, on the ... Global Chemotherapy Induced Nausea And Vomiting Therapeutics Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries ... Serotonin Receptor Antagonists Corticosteroids Benzodiazepines Neurokinin NK1 receptor antagonist Most widely ... Global Chemotherapy Induced Nausea And Vomiting Therapeutics Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect ... Serotonin Receptor Antagonists Corticosteroids Benzodiazepines Neurokinin NK1 receptor antagonist In Chapter 6 and ... |